back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-05-30 15:54 Tx date 2025-05-30 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$2,062
+5,500 vol $0.375 each |
25,000 | |
| Filed 2025-05-30 12:40 Tx date 2025-05-30 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$3,080
+8,000 vol $0.385 each |
19,500 | |
| Filed 2025-05-30 12:38 Tx date 2025-05-29 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$750.00
+2,000 vol $0.375 each |
11,500 | |
| Filed 2025-05-30 12:37 Tx date 2025-05-27 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$770.00
+2,000 vol $0.385 each |
9,500 | |
| Filed 2025-05-30 12:37 Tx date 2025-05-27 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$1,125
+3,000 vol $0.375 each |
7,500 | |
| Filed 2025-05-30 12:36 Tx date 2025-05-27 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$1,687
+4,500 vol $0.375 each |
4,500 | |
| Filed 2025-05-30 12:35 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-28 04:54 Tx date 2024-09-25 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,500
+30,000 vol $0.45 each |
180,000 | |
| Filed 2023-03-04 00:34 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 |